Article BioTech Health Policy 
Health Populi
NOVEMBER 12, 2019
You can read more details about this evolving situation in the WSJ article linked above, and other takes in tech, business, and social media that have begun to populate the interwebs. health care. Was this due to the growing experience and reporting of surprise medical bills?
Health Populi
JANUARY 18, 2019
It is bittersweet to read the latter half of the title, as our friend and mentor Professor Reinhardt, a health economics pioneer, passed away last year. He co-wrote the first “It’s The Prices Stupid” research article in Health Affairs with Gerard Anderson et. Two news items illustrate this issue in real time.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
MARCH 11, 2021
The coolest thing in health policy in the 21st century!! ” Amitabh Chandra gave the opening context-setting talk about the effects of health care cost-sharing on patients-as-consumers. Kavita Patel to assert in the first panel of the day that, “2713 is my favorite number.”
Health Populi
AUGUST 16, 2021
There is one health care public policy issue that unites U.S. Note in Exhibit 1 from the article the process and outcomes of UM programs for each of the stakeholders. voters across political party: that is the consumer-facing costs of prescription drugs. Every one of the processes generates a cost.
Health Populi
JUNE 18, 2020
The New England Journal of Medicine published an essay on June 4, 2020, titled, Specialty Drugs–A Distinctly American Phenomenon (my apologies–the article is behind the NEJM paywall). The phrase “specialty drugs” originated in the 1970s in the advent of injectable and infusion therapies.
Health Populi
JULY 1, 2019
When this occurred, it didn’t cause more than a ripple of interest outside biotech. Jane Sarasohn-Kahn Bio and her Blog, Health Populi. To address that challenge, in 2017 PLM secured a $100 million (controlling interest) investment from iCarbonX , a Chinese company that is amassing patient data to discover cures for disease.
Health Populi
MAY 8, 2019
Yesterday’s Wall Street Journal featured an article on A $2 Million Therapy About to Hit [the] Market , discussing a new gene therapy treatment that addresses spinal muscular atrophy (SMA).
Expert insights. Personalized for you.
166 
Let's personalize your content